Selective estrogen receptor modulators, (SERMs), such as Evista (raloxifine) has been shown to reduce the risk of some forms of osteoporosis in women after menopause. Appears to be an effective SERM, which mimics the stimulating effect of estrogen on bone to produce stronger bones and reduces cholesterol levels, while no stimulatory effect on breast and uterine tissue, effects that may contribute to cancer. It was approved for use in Europe for the buy lasix generic reduction and prevention of osteoporosis fractures in post-menopausal and menopausal women with high risk. emphasize the need Treament options for women who fear or intolerance of the drug this menu. .
No comments:
Post a Comment